6652.TWO
Price:
$6.25
Market Cap:
$856.25M
Eusol Biotech Co.,Ltd. focuses on research and development of new biotech drugs for sleep disorders. Its pipeline includes ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) for repairing neuron function; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with sedative effect. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2018-08-29
Stock Exchange
TWO
Ticker
6652.TWO
According to Eusol Biotech Co.,Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 43.56. This represents a change of -5.53% compared to the average of 46.11 of the last 4 quarters.
The mean historical Current Ratio of Eusol Biotech Co.,Ltd. over the last ten years is 15.20. The current 43.56 Current Ratio has changed 28.56% with respect to the historical average. Over the past ten years (40 quarters), 6652.TWO's Current Ratio was at its highest in in the June 2023 quarter at 53.81. The Current Ratio was at its lowest in in the June 2016 quarter at 0.
Average
15.20
Median
3.08
Minimum
0
Maximum
52.68
Discovering the peaks and valleys of Eusol Biotech Co.,Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Current Ratio = 52.68
Minimum Annual Increase = 0%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 50.05 | -4.99% |
| 2023 | 52.68 | 88.72% |
| 2022 | 27.92 | 84.21% |
| 2021 | 15.15 | 145.80% |
| 2020 | 6.17 | 290.49% |
| 2019 | 0.00 | Infinity% |
| 2018 | 0 | 0% |
| 2017 | 0 | 0% |
| 2016 | 0 | 0% |
| 2015 | 0 | 0% |
The current Current Ratio of Eusol Biotech Co.,Ltd. (6652.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
43.55
5-year avg
30.39
10-year avg
15.20
Eusol Biotech Co.,Ltd.’s Current Ratio is greater than NatureWise Biotech & Medicals Corporation (11.89), greater than SynCore Biotechnology Co.,Ltd (11.18), greater than Andros Pharmaceuticals Co.,Ltd (13.81), greater than LAUNXP Biomedical Co., Ltd (7.53), greater than TCI GENE Inc. (5.74), greater than S&S Healthcare Holding Ltd. (3.26), greater than Level Biotechnology Inc. (1.63), greater than Bio Preventive Medicine Corp. (19.06), greater than Lukas Biomedical Inc. (1.21), greater than BioLASCO Taiwan Co., Ltd. (2.48),
| Company | Current Ratio | Market cap |
|---|---|---|
| 11.89 | $1.04B | |
| 11.18 | $909.02M | |
| 13.81 | $1.26B | |
| 7.53 | $1.12B | |
| 5.74 | $984.26M | |
| 3.26 | $858.24M | |
| 1.63 | $1.08B | |
| 19.06 | $1.14B | |
| 1.21 | $1.33B | |
| 2.48 | $815.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eusol Biotech Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eusol Biotech Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Eusol Biotech Co.,Ltd.'s Current Ratio?
How is the Current Ratio calculated for Eusol Biotech Co.,Ltd. (6652.TWO)?
What is the highest Current Ratio for Eusol Biotech Co.,Ltd. (6652.TWO)?
What is the 3-year average Current Ratio for Eusol Biotech Co.,Ltd. (6652.TWO)?
What is the 5-year average Current Ratio for Eusol Biotech Co.,Ltd. (6652.TWO)?
How does the current Current Ratio for Eusol Biotech Co.,Ltd. (6652.TWO) compare to its historical average?